Next Article in Journal
Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions
Previous Article in Journal
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover
Previous Article in Special Issue
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
 
 
Review

Article Versions Notes

Cancers 2020, 12(7), 1729; https://doi.org/10.3390/cancers12071729
Action Date Notes Link
article pdf uploaded. 29 June 2020 14:31 CEST Version of Record https://www.mdpi.com/2072-6694/12/7/1729/pdf-vor
article pdf uploaded. 29 June 2020 14:32 CEST Updated version of record https://www.mdpi.com/2072-6694/12/7/1729/pdf-vor
article xml file uploaded 10 July 2020 10:33 CEST Original file -
article xml uploaded. 10 July 2020 10:33 CEST Update https://www.mdpi.com/2072-6694/12/7/1729/xml
article pdf uploaded. 10 July 2020 10:33 CEST Updated version of record https://www.mdpi.com/2072-6694/12/7/1729/pdf
article html file updated 10 July 2020 10:34 CEST Original file -
article html file updated 30 July 2020 15:19 CEST Update -
article html file updated 21 July 2022 22:26 CEST Update https://www.mdpi.com/2072-6694/12/7/1729/html
Back to TopTop